These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 12356120)

  • 1. Panic attacks associated with citalopram.
    Brauer HR; Nowicki PW; Catalano G; Catalano MC
    South Med J; 2002 Sep; 95(9):1088-9. PubMed ID: 12356120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exacerbation of panic disorder with rifampin therapy in a patient receiving citalopram.
    Kukoyi O; Argo TR; Carnahan RM
    Pharmacotherapy; 2005 Mar; 25(3):435-7. PubMed ID: 15843291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Efficacy and tolerability of escitalopram in anxiety disorders: a review].
    Pelissolo A
    Encephale; 2008 Sep; 34(4):400-8. PubMed ID: 18922243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.
    Stahl SM; Gergel I; Li D
    J Clin Psychiatry; 2003 Nov; 64(11):1322-7. PubMed ID: 14658946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citalopram-induced major depression in a patient with panic disorder - a case report.
    Hofmann P; Conrad R
    Psychiatr Danub; 2012 Mar; 24(1):94-6. PubMed ID: 22447093
    [No Abstract]   [Full Text] [Related]  

  • 6. Serotonin syndrome associated with the use of escitalopram.
    Huska MT; Catalano G; Catalano MC
    CNS Spectr; 2007 Apr; 12(4):270-4. PubMed ID: 17426664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of citalopram in panic disorder.
    Wade AG; Lepola U; Koponen HJ; Pedersen V; Pedersen T
    Br J Psychiatry; 1997 Jun; 170():549-53. PubMed ID: 9330022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis of epilepsy complicated by panic disorder and a non-specific reaction to a SSRI].
    Wanders AJ; de Leeuw AS; van Megen HJ
    Tijdschr Psychiatr; 2010; 52(5):349-52. PubMed ID: 20458682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sertraline-induced panic attack.
    González-Berríos N
    Bol Asoc Med P R; 2009; 101(1):59-60. PubMed ID: 19954091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A naturalistic long-term comparison study of selective serotonin reuptake inhibitors in the treatment of panic disorder.
    Dannon PN; Iancu I; Lowengrub K; Gonopolsky Y; Musin E; Grunhaus L; Kotler M
    Clin Neuropharmacol; 2007; 30(6):326-34. PubMed ID: 18090457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serotonin, panic disorder and agoraphobia: short-term and long-term efficacy of citalopram in panic disorders.
    Humble M; Wistedt B
    Int Clin Psychopharmacol; 1992 Jun; 6 Suppl 5():21-39. PubMed ID: 1431019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case with euprolactinemic galactorrhea induced by escitalopram.
    Gulsun M; Algul A; Semiz UB; Ates MA; Doruk A; Ebrinc S; Basoglu C; Cetin M
    Int J Psychiatry Med; 2007; 37(3):275-8. PubMed ID: 18314855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tryptophan depletion does not modify response to CCK-4 challenge in patients with panic disorder after treatment with citalopram.
    Tõru I; Shlik J; Maron E; Vasar V; Nutt DJ
    Psychopharmacology (Berl); 2006 May; 186(1):107-12. PubMed ID: 16541242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paroxetine : a review of its pharmacology and therapeutic potential in the management of panic disorder.
    Foster RH; Goa KL
    CNS Drugs; 1997 Aug; 8(2):163-88. PubMed ID: 23338224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The emergence of tics during escitalopram and sertraline treatment.
    Altindag A; Yanik M; Asoglu M
    Int Clin Psychopharmacol; 2005 May; 20(3):177-8. PubMed ID: 15812270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reboxetine and citalopram in panic disorder: a single-blind, cross-over, flexible-dose pilot study.
    Seedat S; van Rheede van Oudtshoorn E; Muller JE; Mohr N; Stein DJ
    Int Clin Psychopharmacol; 2003 Sep; 18(5):279-84. PubMed ID: 12920388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The side effect burden associated with drug treatment of panic disorder.
    Baldwin DS; Birtwistle J
    J Clin Psychiatry; 1998; 59 Suppl 8():39-44; discussion 45-6. PubMed ID: 9707161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of citalopram treatment on behavioural, cardiovascular and neuroendocrine response to cholecystokinin tetrapeptide challenge in patients with panic disorder.
    Shlik J; Aluoja A; Vasar V; Vasar E; Podar T; Bradwejn J
    J Psychiatry Neurosci; 1997 Nov; 22(5):332-40. PubMed ID: 9401314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of 6-week treatment with escitalopram on CCK-4 challenge: a placebo-controlled study in CCK-4-sensitive healthy volunteers.
    Tõru I; Maron E; Raag M; Vasar V; Nutt DJ; Shlik J
    Eur Neuropsychopharmacol; 2013 Jul; 23(7):645-52. PubMed ID: 22939006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.